Research Lab

The Melero-Martin Lab

see all publications in PubMed

2012

  • Inflamed tumor-associated adipose tissue is a depot for macrophages that stimulate tumor growth and angiogenesis. Wagner M, Bjerkvig R, Wiig H,  Melero-Martin JM, Lin RZ, Klagsbrun M, Dudley AC. Angiogenesis 2012; 15(3):481-95. PDF
  • Equal modulation of endothelial cell function by four distinct tissue-specific mesenchymal stem cells. Lin RZ, Moreno-Luna R, Zhou B, Pu WT, Melero-Martin JM. Angiogenesis 2012; 15(3):443-55. PDF
  • Fibroblast growth factor-2 facilitates rapid anastomosis formation between bioengineered human vascular networks and living vasculature. Lin RZ, Melero-Martin JM. Methods 2012; 56(3):440-51. PDF
  • Functional human vascular network generated in photocrosslinkable gelatin methacrylate hydrogels. Chen YC+, Lin RZ+, Qi H, Yang Y, Bae H, Melero-Martin JM*, Khademhosseini A*. Adv Funct Mater 2012; 22(10):2027-39. (+co-first authors; * co-corresponding authors) PDF
  • Thymosin beta 4 treatment after myocardial infarction does not reprogram epicardial cells into cardiomyocytes. Zhou B, Honor LB, Ma Q, Oh JH, Lin RZ, Melero-Martin JM, von Gise A, Zhou P, Hu T, He L, Wu KH, Zhang H, Zhang Y, Pu WT.  J Mol Cell Cardiol 2012; 52(1):43-7. PDF

 

2011

  • Induction of erythropoiesis using human vascular networks genetically-engineered for controlled erythropoietin release. Lin RZ, Dreyzin A, Aamodt K, Li D, Jaminet SCS, Dudley AC, Melero-Martin JM.  Blood 2011; 118(20):5420-8. PDF   Suppl.
  • Bioengineering human microvascular networks in immunodeficient mice. Lin RZ, Melero-Martin JM.  J Vis Exp 2011; Jul 11;(53).pii:3065 . PDF   VIDEO
  • Adult mouse epicardium modulates myocardial injury by secreting paracrine factors. Zhou B, Honor LB, He H, Ma Q, Oh JH, Butterfield C, Lin RZ, Melero-Martin JM, Dolmatova E, Duffy HS, Gise AV, Zhou P, Hu YW, Wang G, Zhang B, Wang L, Hall JL, Moses MA, McGowan FX, Pu WT. J Clin Invest 2011; 121:1894-1904. PDF
  • Type I collagen, fibrin and Puamatrix matrices provide permissive environments for human endothelial and mesenchymal progenitor cells to form neovascular networks. Allen P, Melero-Martin JM, Bischoff J. J Tissue Eng Regen Med 2011; Apr 5(4):e74-86. PDF
  • Concise review: vascular stem cells and tumor angiogenesis. Melero-Martin JM, Dudley AC. Stem Cells 2011; 29:163-8. PDF
  • Functional endothelial progenitor cells from cryopreserved umbilical cord blood. Lin RZ, Dreyzin A, Aamodt K, Dudley AC, Melero-Martin JM. Cell Transplant 2011; 20:515-522. PDF

 

2010

  • Bone marrow is a reservoir for pro-angiogenic myelomonocytic cells but not endothelial cells in spontaneous tumors. Dudley AC, Udagawa T, Melero-Martin JM, Shih SC, Curatolo A, Moses M, Klagsbrun M. Blood 2010; 116:3367-3371. PDF
  • Host myeloid cells are necessary for creating bio-engineered human vascular networks in vivo. Melero-Martin JM, De Obaldia ME, Allen P, Dudley AC, Klagsbrun M, Bischoff J. Tissue Eng Part A 2010; 16:2457-2466. PDF
  • In vivo monitoring of autologous engineered pulmonary valve function. Gottlieb D, Tandon K, Emani S, Aikawa E, Brown DW, Powell AJ, Nedder A, Engelmayr GC, Melero-Martin JM, Sacks MS, Mayer JE Jr. J Thorac Cardiovasc Surg 2010; 139:723-731. PDF
  • Molecular imaging of small-diameter tissue-engineered vascular grafts: a feasibility study. Hjortnaes J, Gottlieb D, Figueiredo JL, Melero-Martin JM, Kohler RH, Bischoff J, Weissleder R, Mayer, J, Aikawa E. Tissue Eng Part C Methods 2010; 16:597-607. PDF

 

2009

  • Methodology for optimal in vitro cell expansion in tissue engineering. Melero-Martin JM, Santhalingam S, Al-Rubeai M.  Adv Biochem Eng Biotechnol 2009; 112:209-29. PDF

 

2008

  • Engineering robust and functional vascular networks in vivo with human adult and cord blood-derived progenitor cells. Melero-Martin JM, De Obaldia ME, Kang S-Y, Khan ZA, Yuan L, Oettgen P, Bischoff J. Circ Res 2008; 103:194-202. PDF  (Best paper award 2009)
  • Chapter 13: An in vivo experimental model for postnatal vasculogenesis. Melero-Martin JM, Bischoff J. Methods Enzymol 2008; 445:303-329. PDF
  • Multipotential stem cells recapitulate human infantile hemangioma in immunodeficient mice. Khan ZA, Boscolo E, Picard A, Psutka S, Melero-Martin JM, Bartch TC, Mulliken JB, Bischoff J. J Clin Invest 2008; 118: 2592-2599. PDF

 

2007

  • In vivo vasculogenic potential of human blood-derived endothelial progenitor cells. Melero-Martin JM, Khan ZA, Picard A, Wu X, Paruchuri S, Bischoff J. Blood 2007; 109:4761-4768. PDF

 

2006

  • Human pulmonary valve progenitor cells exhibit endothelial/mesenchymal plasticity in response to VEGF-A and TGFb2. Paruchuri S, Yang JH, Rabkin-Aikawa E, Melero-Martin JM, Khan ZA, Loukogeorgakis S, Schoen FJ, Bischoff J.  Circ Res 2006; 99:861-869. PDF
  • Endothelial progenitor cells from infantile hemangioma and umbilical cord blood display unique cellular responses to Endostatin.  Khan ZA, Melero-Martin JM, Wu X, Paruchuri S, Boscolo E, Mulliken JB, Bischoff J. Blood 2006; 108:915-921. PDF
  • Expansion of chondroprogenitor cells on macroporous microcarriers as an alternative to conventional monolayer systems. Melero-Martin JM, Dowling MA, Smith M, Al-Rubeai M. Biomaterials 2006; 27:2970-2979. PDF
  • Optimal in-vitro expansion of chondroprogenitor cells in monolayer culture. Melero-Martin JM, Dowling MA, Smith M, Al-Rubeai M. Biotechnol Bioeng 2006; 93:519-533. PDF

 

2005

  • Cryopreservation and in-vitro expansion of chondroprogenitor cells isolated from the superficial zone of articular cartilage. Melero Martin JM, Smith M, Al-Rubeai M. Biotechnol Prog 2005; 21:168-177.
LINKS

Google Scholar

PubMed